SCHEMBL16494899

SCHEMBL16494899

NC(=O)[C@@H](N)CC(Cc1ccccc1)C(=O)O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A1 P43005 2/20 0.81
▸ SLC1A3 P43003 1/20 0.81
▸ SLC1A2 P43004 1/20 0.81
▸ CYP1A2 P05177 1/20 0.63
▸ ALPI P09923 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ PTGS1 P23219 1/20 0.59
▸ XIAP P98170 1/20 0.59
▸ SLC7A5 Q01650 1/20 0.59
▸ ANPEP P15144 1/20 0.57
▸ RNPEP Q9H4A4 1/20 0.57
▸ DNPEP Q9ULA0 1/20 0.57
▸ CPA3 P15088 3/20 0.56
▸ CPA1 P15085 2/20 0.56
▸ FOLH1 Q04609 2/20 0.56
▸ CPB1 P15086 1/20 0.56
▸ CPB2 Q96IY4 1/20 0.56
▸ NAALAD2 Q9Y3Q0 1/20 0.55
▸ GRIK1 P39086 1/20 0.54
▸ GRM2 Q14416 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377822 0.89 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL133913 0.89 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL130817 0.89 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL2265548 0.89 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL8959957 0.88 SLC1A1 (0.96) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL1519045 0.86 SLC1A1 (0.81) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL3333369 0.86 SLC1A1 (0.81) SLC1A1SLC1A3SLC1A2CYP1A2ALPI
SCHEMBL9622038 0.85 CYP1A2 (0.86) SLC1A1SLC1A3SLC1A2CYP1A2CPA3
SCHEMBL7439697 0.85 CYP1A2 (0.86) SLC1A1SLC1A3SLC1A2CYP1A2CPA3
SCHEMBL7432418 0.85 CYP1A2 (0.86) SLC1A1SLC1A3SLC1A2CYP1A2CPA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397488-B1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS FEDERAL STATE BUDGETARY INSTITUTION RES ZAKUSOV INSTITUTE OF PHARMACOLOGY (RU) 2019-03-27 — — EP disclosed
US-9683014-B2 Dipeptide mimetics of NGF and BDNF neurotrophins UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII IMENI V.V.ZAKUSOVA RAMN (RU) 2017-06-20 — — US disclosed
US-20150111828-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII (RU) 2015-04-23 — — US disclosed
US-20110312895-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII IMENI V.V.ZAKUSOVA RAMN (RU) 2011-12-22 — — US disclosed
EP-2397488-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS Uchrezhdenie Rossiiskoi Akademii Meditsynskikh Nauk Nauchno-issledovatelsky Institut Farmakologii Imeni V.V.Zakusova Ramn (RU) 2011-12-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111828-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS BDNF, NTRK2, NGF SLC1A1 1230/4885SLC1A3 1723/4885SLC1A2 1010/4885
US-20110312895-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS BDNF, NTRK2, NGF SLC1A1 1230/4885SLC1A3 1723/4885SLC1A2 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback